IL94652A - Carboplatin preparation - Google Patents

Carboplatin preparation

Info

Publication number: IL94652A
Authority: IL; Israel
Prior art keywords: carboplatin; composition; buffered; fact; sodium
Prior art date: 1989-06-06

Application number

IL9465290A

Other languages

English (en)

Hebrew (he)

Other versions

IL94652A0 (en

Original Assignee

Pharmachemie Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-06

Filing date

1990-06-06

Publication date

1994-02-27

1990-06-06 Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv

1991-04-15 Publication of IL94652A0 publication Critical patent/IL94652A0/xx

1994-02-27 Publication of IL94652A publication Critical patent/IL94652A/en

Links

190000008236 Carboplatin Chemical compound 0.000 title claims abstract description 33
229960004562 carboplatin Drugs 0.000 title claims abstract description 33
239000000203 mixture Substances 0.000 title claims abstract description 14
239000007864 aqueous solution Substances 0.000 claims abstract description 5
239000000872 buffer Substances 0.000 claims description 4
239000006172 buffering agent Substances 0.000 claims description 3
239000008363 phosphate buffer Substances 0.000 claims description 2
239000000243 solution Substances 0.000 abstract description 16
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 14
229910000147 aluminium phosphate Inorganic materials 0.000 description 7
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 5
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
239000000824 cytostatic agent Substances 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000000034 method Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
230000007096 poisonous effect Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Powder Metallurgy (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL9465290A 1989-06-06 1990-06-06 Carboplatin preparation IL94652A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8901433A NL8901433A (nl)	1989-06-06	1989-06-06	Carboplatinpreparaat.

Publications (2)

Publication Number	Publication Date
IL94652A0 IL94652A0 (en)	1991-04-15
IL94652A true IL94652A (en)	1994-02-27

Family

ID=19854785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9465290A IL94652A (en)	1989-06-06	1990-06-06	Carboplatin preparation

Country Status (13)

Country	Link
US (1)	US5104896A (fr)
EP (1)	EP0401896B1 (fr)
JP (1)	JP2825934B2 (fr)
AT (1)	ATE92759T1 (fr)
AU (1)	AU630961B2 (fr)
CA (1)	CA2018229C (fr)
DE (1)	DE69002697T2 (fr)
DK (1)	DK0401896T3 (fr)
ES (1)	ES2044405T3 (fr)
FI (1)	FI96276C (fr)
IL (1)	IL94652A (fr)
NL (1)	NL8901433A (fr)
NO (1)	NO301048B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124317A (en)	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.P.A.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) *	1985-08-02	1999-11-02	Pharmacia & Upjohn Company	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
AU5878294A (en) *	1994-02-07	1995-08-21	Kiss Laboratories S.R.O.	Anti-tumour medical preparation on the basis of carboplatin and the method of its production
DE69519300T2 (de) *	1994-08-08	2001-05-31	Debiopharm S.A., Lausanne	Stabiles arzneimittel enthaltend oxaliplatin
CZ292170B6 (cs) *	1998-08-14	2003-08-13	Pliva-Lachema A.S.	Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
CA2397944C (fr) *	2000-01-24	2009-06-09	Bernstein Beteiligungs Gmbh	Appareil de sport, de preference vehicule se deplacant sur la neige ou sur l'eau
AUPQ641100A0 (en) *	2000-03-23	2000-04-15	Australia Nuclear Science & Technology Organisation	Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
WO2003004505A1 (fr) *	2001-07-02	2003-01-16	Debiopharm S.A.	Substance active a base d'oxaliplatine presentant une faible teneur en acide oxalique
AU2005329764B2 (en) *	2005-03-28	2010-08-12	Dabur Pharma Ltd.	Stable pharmaceutical compositions of platinum (II) antitumour agents
US20090130017A1 (en) *	2007-11-19	2009-05-21	Searete Llc	Targeted short-lived drug delivery
KR101127159B1 (ko) *	2009-11-02	2012-03-20	한국생명공학연구원	식물병원성 그람음성 세균의 분비체계를 저해하는 카보프라틴 화합물을 유효성분으로 함유하는 식물병 방제제
KR101055409B1 (ko) *	2010-12-31	2011-08-08	내쇼날씨엔디 주식회사	튜브형 썰매
KR102500135B1 (ko)	2015-02-27	2023-02-17	캐논 가부시끼가이샤	드럼 유닛, 카트리지 및 프로세스 카트리지
US12427104B1 (en)	2025-04-01	2025-09-30	Ingenus Pharmaceuticals, Llc	Injectable carboplatin formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4339437A (en) *	1976-12-27	1982-07-13	Research Corporation	Anti-tumor method
US4873226A (en) *	1983-06-17	1989-10-10	Delta Metals, Inc.	Method of inhibiting herpetic lesions by the use of platinum coordination compounds
NL8303657A (nl) *	1983-10-24	1985-05-17	Pharmachemie Bv	Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
GB8416048D0 (en) *	1984-06-22	1984-07-25	Johnson Matthey Plc	Anti-tumour compounds of platinum
CS269719B1 (en) *	1986-12-29	1990-05-14	Kiss Frantisek	Platinum cytostatic

1989
- 1989-06-06 NL NL8901433A patent/NL8901433A/nl not_active Application Discontinuation
1990
- 1990-05-28 EP EP90201354A patent/EP0401896B1/fr not_active Expired - Lifetime
- 1990-05-28 AT AT90201354T patent/ATE92759T1/de not_active IP Right Cessation
- 1990-05-28 DK DK90201354.9T patent/DK0401896T3/da active
- 1990-05-28 ES ES90201354T patent/ES2044405T3/es not_active Expired - Lifetime
- 1990-05-28 DE DE90201354T patent/DE69002697T2/de not_active Expired - Fee Related
- 1990-05-29 US US07/529,917 patent/US5104896A/en not_active Expired - Lifetime
- 1990-05-31 FI FI902713A patent/FI96276C/fi not_active IP Right Cessation
- 1990-06-04 CA CA002018229A patent/CA2018229C/fr not_active Expired - Fee Related
- 1990-06-05 NO NO902488A patent/NO301048B1/no not_active IP Right Cessation
- 1990-06-05 AU AU56296/90A patent/AU630961B2/en not_active Ceased
- 1990-06-06 JP JP2146385A patent/JP2825934B2/ja not_active Expired - Fee Related
- 1990-06-06 IL IL9465290A patent/IL94652A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
US5104896A (en)	1992-04-14
FI96276C (fi)	1996-06-10
DE69002697D1 (de)	1993-09-16
FI96276B (fi)	1996-02-29
IL94652A0 (en)	1991-04-15
NO902488L (no)	1990-12-07
DK0401896T3 (da)	1993-11-15
CA2018229A1 (fr)	1990-12-06
ES2044405T3 (es)	1994-01-01
JPH0356420A (ja)	1991-03-12
AU5629690A (en)	1990-12-13
AU630961B2 (en)	1992-11-12
NL8901433A (nl)	1991-01-02
NO301048B1 (no)	1997-09-08
EP0401896A1 (fr)	1990-12-12
JP2825934B2 (ja)	1998-11-18
ATE92759T1 (de)	1993-08-15
NO902488D0 (no)	1990-06-05
DE69002697T2 (de)	1994-02-10
FI902713A0 (fi)	1990-05-31
CA2018229C (fr)	1998-04-07
EP0401896B1 (fr)	1993-08-11

Legal Events

Date	Code	Title
1996-10-16	KB	Patent renewed
2004-07-25	KB	Patent renewed
2009-07-27	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL94652A (en)	1994-02-27	Carboplatin preparation
US4931441A (en)	1990-06-05	Stabilized aqueous leucovorin calcium compositions
AU2652001A (en)	2001-08-27	Stable, nasally, orally or sublingually applicable pharmaceutical preparation
EP0398207B1 (fr)	1994-08-10	Forme liquide stable de l'acide amino-5 salicylique
EP0098073B1 (fr)	1988-12-14	Composition pharmaceutique en poudre, contenant de la myéloperoxidase
DE60030070T2 (de)	2007-02-15	Iodierte proteine zur vorbeugung von iodmangelzuständen
US3940480A (en)	1976-02-24	Process for production of stabilized powdery secretin preparation by lyophilization
DE2639849A1 (de)	1977-03-17	Verfahren zur herstellung stabiler praeparate wasserloeslicher salze von dehydroepiandrosteronsulfat zur parenteralen verabreichung
JP2002370908A (ja)	2002-12-24	保存剤
CS240957B2 (en)	1986-03-13	Production method of stabile solution containing iron and selenium
US2955981A (en)	1960-10-11	Prevention of iron-deficiency anemias in suckling mammals
US2939821A (en)	1960-06-07	Stable solutions containing vitamin b12
US6613767B1 (en)	2003-09-02	Stable aqueous folinate solution
DE69910610T2 (de)	2004-06-17	Herstellung trockener, in wasser löslicher zusammensetzungen zur vermeidung der maillard-reaktion im trockenen zustand und ihre anwendungen
CA2109053C (fr)	2004-02-10	Solutions stabilisees d'hexadecylphosphocholine dans des ethers alkyliques de glycerol
US3155587A (en)	1964-11-03	Stable liquid preparations of 7-chlorotetracycline
EP3996720A1 (fr)	2022-05-18	Supplément nutritionnel injectable
US3113073A (en)	1963-12-03	Solutions of benzoquinone derivatives
US6187818B1 (en)	2001-02-13	Prostaglandins formulation and process
SK278421B6 (en)	1997-05-07	Parenterally applicable pharmaceutical composition containing bis-indole alkaloid and preparation method thereof
SU1697696A1 (ru)	1991-12-15	Способ стабилизации йодидов в премиксах
US5192784A (en)	1993-03-09	Etanidazole injectable solution
JPS60260510A (ja)	1985-12-23	ケトン症治療用の注射溶液
US3692910A (en)	1972-09-19	Benzylisoquinolinic solutions and method of making the same
Linkenheimer et al.	1960	Preparation and biological testing of a parenteral iron preparation